Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A 24-week Phase III Study to Evaluate the Efficacy and Tolerability of Beclometasone/Formoterol Single Inhaler HFA 134a-pMDI in Adult Patients With Moderate to Severe Persistent Asthma
Brief Summary: Efficacy and tolerability of the fixed combination beclometasone/formoterol in patients with moderate to severe persistent asthma.


Options:
A: Arm Label: ADVAIR 100/50mcg; Type: EXPERIMENTAL; Interventions: Drug: ADVAIR 100/50mcg | Arm Label: ADVAIR 250/50mcg; Type: EXPERIMENTAL; Interventions: Drug: ADVAIR 250/50mcg | Arm Label: ADVAIR 500/50mcg; Type: EXPERIMENTAL; Interventions: Drug: ADVAIR 500/50mcg | Arm Label: FLOVENT 100mcg; Type: ACTIVE_COMPARATOR; Interventions: Drug: FLOVENT 100mcg | Arm Label: FLOVENT 250mcg; Type: ACTIVE_COMPARATOR; Interventions: Drug: FLOVENT 250mcg | Arm Label: FLOVENT 500mcg; Type: ACTIVE_COMPARATOR; Interventions: Drug: FLOVENT 500mcg | Intervention Type: DRUG; Name: ADVAIR 100/50mcg; Assigned to Arm(s): ADVAIR 100/50mcg | Intervention Type: DRUG; Name: ADVAIR 250/50mcg; Assigned to Arm(s): ADVAIR 250/50mcg | Intervention Type: DRUG; Name: ADVAIR 500/50mcg; Assigned to Arm(s): ADVAIR 500/50mcg | Intervention Type: DRUG; Name: FLOVENT 100mcg; Assigned to Arm(s): FLOVENT 100mcg | Intervention Type: DRUG; Name: FLOVENT 250mcg; Assigned to Arm(s): FLOVENT 250mcg | Intervention Type: DRUG; Name: FLOVENT 500mcg; Assigned to Arm(s): FLOVENT 500mcg
B: Arm Label: Fp MDPI 50 mcg; Type: EXPERIMENTAL; Interventions: Drug: Fp MDPI, Drug: albuterol/salbutamol | Arm Label: Fp MDPI 100 mcg; Type: EXPERIMENTAL; Interventions: Drug: Fp MDPI, Drug: albuterol/salbutamol | Arm Label: Fp MDPI 200 mcg; Type: EXPERIMENTAL; Interventions: Drug: Fp MDPI, Drug: albuterol/salbutamol | Arm Label: Fp MDPI 400 mcg; Type: EXPERIMENTAL; Interventions: Drug: Fp MDPI, Drug: albuterol/salbutamol | Arm Label: Placebo MDPI; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo MDPI, Drug: albuterol/salbutamol | Arm Label: Flovent Diskus 250mcg; Type: ACTIVE_COMPARATOR; Interventions: Drug: Flovent Diskus, Drug: albuterol/salbutamol | Intervention Type: DRUG; Name: Fp MDPI; Assigned to Arm(s): Fp MDPI 100 mcg, Fp MDPI 200 mcg, Fp MDPI 400 mcg, Fp MDPI 50 mcg | Intervention Type: OTHER; Name: Placebo MDPI; Assigned to Arm(s): Placebo MDPI | Intervention Type: DRUG; Name: Flovent Diskus; Assigned to Arm(s): Flovent Diskus 250mcg | Intervention Type: DRUG; Name: albuterol/salbutamol; Assigned to Arm(s): Flovent Diskus 250mcg, Fp MDPI 100 mcg, Fp MDPI 200 mcg, Fp MDPI 400 mcg, Fp MDPI 50 mcg, Placebo MDPI
C: Arm Label: beclometasone /formoterol; Type: EXPERIMENTAL; Interventions: Drug: beclomethasone/formoterol (100/6µg) pMDI | Arm Label: Beclomethasone; Type: ACTIVE_COMPARATOR; Interventions: Drug: Beclometasone dipropionate 250 µg/unit dose pMDI | Arm Label: Formoterol powder 12 µg/unit dose; Type: ACTIVE_COMPARATOR; Interventions: Drug: Formoterol powder 12 µg/unit dose | Intervention Type: DRUG; Name: beclomethasone/formoterol (100/6µg) pMDI; Assigned to Arm(s): beclometasone /formoterol | Intervention Type: DRUG; Name: Beclometasone dipropionate 250 µg/unit dose pMDI; Assigned to Arm(s): Beclomethasone | Intervention Type: DRUG; Name: Formoterol powder 12 µg/unit dose; Assigned to Arm(s): Formoterol powder 12 µg/unit dose
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: budesonide/formoterol (Symbicort) | Intervention Type: DRUG; Name: budesonide/formoterol (Symbicort); Assigned to Arm(s): 1

Answer: C